[Differentiation of resistance phenotypes among erythromycin-resistant streptococci]

Danijela Bejuk1

  • 1Zavod za klinicku mikrobiologiju i hospitalne infekcije, Opća bolnica Sveti Duh, Zagreb, Hrvatska. danijela.bejuk@zg.htnet.hr

Insights

Macrolide antibiotic resistance in streptococci, particularly Streptococcus pneumoniae, is a growing concern. New resistance mechanisms like the M phenotype and complex MLSb resistance require accurate diagnostic methods for effective antibiotic selection.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Clinical Medicine

Context:

  • Macrolide antibiotics are crucial for treating respiratory tract infections.
  • Increasing resistance in streptococci, especially Streptococcus pneumoniae, poses a therapeutic challenge.
  • Emergence of cross-resistance to macrolides, lincosamides, and streptogramins (MLSb) is a significant issue.

Purpose:

  • To investigate the prevalence and characteristics of macrolide resistance phenotypes in streptococci.
  • To evaluate diagnostic methods for differentiating M and MLSb resistance mechanisms.
  • To understand the genotypic and phenotypic variations of MLSb resistance in Streptococcus pyogenes and Streptococcus pneumoniae.

Summary:

  • Two main resistance mechanisms are identified: the M phenotype (efflux-mediated) and the MLSb phenotype (methylase-mediated).
  • The erythromycin-clindamycin double-disc (ECDD) method reliably differentiates M from MLSb resistance in S. pyogenes and S. pneumoniae.
  • Distinguishing constitutive (cMLS) from inducible (iMLS) MLSb resistance is straightforward in S. pyogenes but challenging in S. pneumoniae, necessitating advanced triple-disk tests.

Impact:

  • Accurate differentiation of resistance phenotypes is essential for guiding antibiotic therapy choices.
  • Understanding resistance mechanisms aids in developing strategies to combat antimicrobial resistance.
  • The study highlights the need for refined diagnostic tools to manage macrolide resistance in clinical settings.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...